RMTC Holding Clenbuterol Decision for Study Results

Boehringer Ingelheim Vetmedica, Inc., has commended the Racing Medication and Testing Consortium (RMTC) for its recent decision to wait on the results of a UC Davis study before ruling on a possible ban of clenbuterol at horse racing tracks.

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners